| | Case Number | Title | Investigator |
| Select | 574 | 2, 4-Diamino-6-(bridged diaryl) Aminomethylpteridines and Related Drugs Against Toxoplasmosis and Other Opportunistic Infections | A. Rosowsky |
| Select | 534 | PGC-1, a Novel Brown Fat PPAR Coactivator | B. Spiegelman |
| Select | 485 | Use of PPAR Agents in the Treatment of Tumors of Fat | B. Spiegelman |
| Select | 697 | PGC-1 Isoforms | B. Spiegelman |
| Select | 707 | PGC-1 and Gluconeogenesis. | B. Spiegelman |
| Select | 794 | PGC-1 Beta, a Novel Nuclear Receptor Coactive Related to PGC-1 | B. Spiegelman |
| Select | 811 | Induction of Slow-Twitch Muscle Fiber Program by PGC-1 | B. Spiegelman |
| Select | 350 | Methods of Inhibiting Undesirable Cell Growth Using a Combination of a Creatine Compound and a Hyperplastic Inhibitory Agent | D. Kufe |
| Select | 792 | Treatment of Oxidative Damage | D. Kufe |
| Select | 761 | Neutralizing Anti-Envelope Antibody Specificities and Binding Parameters on Development of Vaccines for Retroviral Infections Including HIV and SIV | E. Reinherz |
| Select | 892 | High Affinity mAbs Binding to Smallpox and Vaccinia Growth Factors | E. Reinherz |
| Select | 509 | Culturing B-Cells for use as Antigen Presenting Cells | G. Freeman |
| Select | 548 | Retroviral Vectors with Deletions in Matrix Protein for Use in Gene Therapy | H. Gottlinger |
| Select | 611 | Non-Integrating Retroviral Gene Therapy Vectors | J. Sodroski |
| Select | 861 | Use of Proteosome Inhibitors to Enhance Sensitivity to or Overcome Resistance to Chemotherapy | K. Anderson |
| Select | 852 | Use of Sparc/Osteonectin/BM40 and its Homologues to Enhance Cancer Therapy | L. Chen |
| Select | 270 | Composition and Method for Treating Cancer | L. Chen |
| Select | 595 | The Catalytic Subunit of Human Telomerase (hTERT) is a Tumor-Associated Target for Cytotoxic T Lymphocytes in a Wide Range of Cancers | L. Nadler |
| Select | 641 | Cytochrome P450 1B1 is a Universal Tumor Antigen Eliciting Cytotoxic T Cell Responses | L. Nadler |
| Select | 762 | Universal Professional Antigen-Presenting Cells Which Can Endogenously Express, Naturally Process, and Present Antigenic Peptides | L. Nadler |
| Select | 801 | BID-Binding Inducer of Mitochondrial Dysfunction | S. Korsmeyer |
| Select | 902 | Method of Treating of the von-Hippel-Lindau Disease | W. Kaelin |
| Select | 562 | Humanized Anti-TAT sFv Intrabody | W. Marasco |
| Select | 255 | Method of Intracellular Binding of Proteins | W. Marasco |